Jake Shortt

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Topics

Acute Myeloid Leukemia

Stem Cell Transplantation

Top Venues

European journal of haematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Jake Shortt, Stephen Samuel Opat
Large cell lymphoma through a liquid lens. British journal of haematology 205 (1) (2024)
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Limei Michelle Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia S Y Ai, Ashley Beekman, Pietro R Di Ciaccio, Michael Krigstein, Joel C Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir Jing Ho, Tara Cochrane, Eliza A Hawkes, Chan Yoon Y Cheah, Stephen Samuel Opat, Gareth Peter Gregory
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. EJHaem 5 (4) (2024)
David T Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes Sm Yong, Jake Shortt, Lynette Chee, Nicholas Viiala, Ilona Cunningham, David Morrall Ross, Alwyn Bernard D'Souza, Matthew Wright, Rosemary Anne Harrup, Cecily Jane Forsyth, Robin Filshie, Steven W Lane, Peter J Browett, Carolyn S Grove, Andrew A Grigg, Timothy P Hughes
Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study. Blood (2024)
Jake Shortt, Stephen Samuel Opat
Large cell lymphoma through a liquid lens. British journal of haematology (2024)
Matteo Costacurta, Jarrod J Sandow, Belinda Maher, Olivia Susanto, Stephin J Vervoort, Jennifer R Devlin, Daniel Garama, Mark R Condina, Joel R Steele, Hossein V Kahrood, Daniel Gough, Ricky W Johnstone, Jake Shortt
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling. The FEBS journal (2024)
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Limei Michelle Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia S Y Ai, Ashley Beekman, Pietro R Di Ciaccio, Michael Krigstein, Joel C Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir Jing Ho, Tara Cochrane, Eliza A Hawkes, Chan Yoon Y Cheah, Stephen Samuel Opat, Gareth Peter Gregory
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance. EJHaem 5 (4) (2024)
Amanda Tey, James Schwarer, Robert Raffa, Emily Shi, Eldho Paul, Stephen Samuel Opat, Claire Dendle, Jake Shortt
High risk of infection in 'real-world' patients receiving ibrutinib, idelalisib or venetoclax for mature B-cell leukaemia/lymphoma. European journal of haematology (2023)
Allison Mo, Robert Weinkove, Erica Michelle Wood, Jake Shortt, Anna Johnston, Zoe K McQuilten, null null
Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice survey. European journal of haematology (2023)
Allison Mo, Erica Wood, Jake Shortt, Erin Hu, Zoe K McQuilten
Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes. European journal of haematology (2023)
Maciej Tatarczuch, Mark Waltham, Jake Shortt, Galina Polekhina, Eliza A Hawkes, Shir-Jing Ho, Judith Trotman, Daniella Brasacchio, Melannie Co, Jessica Li, Vanitha Ramakrishnan, Karin Dunne, Stephen Samuel Opat, Gareth Peter Gregory
Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma. Blood advances (2023)
Danielle H Oh, Xiao Ma, Simon J Hogg, Jackson He, Conor Kearney, Daniella Brasacchio, Olivia Susanto, Belinda Maher, Ian G Jennings, Andrea Newbold, Peter Fraser, Emily Gruber, Lev M Kats, Gareth P Gregory, Ricky W Johnstone, Philip E Thompson, Jake Shortt
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma. Proceedings of the National Academy of Sciences of the United States of America 120 (36) (2023)
Amanda Tey, James Schwarer, Robert Raffa, Emily Shi, Eldho Paul, Stephen Opat, Claire Dendle, Jake Shortt
High risk of infection in 'real-world' patients receiving ibrutinib, idelalisib or venetoclax for mature B-cell leukaemia/lymphoma. European journal of haematology (2023)
Allison Mo, Robert Weinkove, Erica Michelle Wood, Jake Shortt, Anna Johnston, Zoe K McQuilten, null null
Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice survey. European journal of haematology 112 (4) (2023)
Allison Mo, Robert Weinkove, Erica Michelle Wood, Jake Shortt, Anna Johnston, Zoe K McQuilten, null null
Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice survey. European journal of haematology 112 (4) (2023)
Jonathan Wong, Emily Gruber, Belinda Maher, Mark Waltham, Zahra Sabouri-Thompson, Ian Jong, Quinton Luong, Sidney Levy, Beena Kumar, Daniella Brasacchio, Wendy Jia, Joan So, Hugh Skinner, Alexander Lewis, Simon J Hogg, Stephin Vervoort, Carmen DiCorleto, Micheleine Uhe, Jeanette Gamgee, Stephen Samuel Opat, Gareth P Gregory, Galina Polekhina, John Reynolds, Eliza A Hawkes, Gajan Kailainathan, Robin Gasiorowski, Lev M Kats, Jake Shortt
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. Leukemia 36 (6) (2022)
Aditya Tedjaseputra, James A Kuzich, Nisha Thiagarajah, Tse-Chieh Teh, Julia McClelland, Marzia Rahman, Rowena Brook, Chong Chyn Chua, Doen Ming Ong, Shuh-Ying Tan, Robin Filshie, Chun Yew Fong, Pasquale Fedele, Ashish Bajel, Jake Shortt, Andrew H Wei
Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic. Leukemia & lymphoma 63 (11) (2022)
Guillermo Garcia Manero, Valeria Santini, Antonio Almeida, Uwe Platzbecker, Anna Jonasova, Lewis R Silverman, Jose Falantes, Gianluigi Reda, Francesco Buccisano, Pierre Fenaux, Rena Buckstein, Maria Diez Campelo, Stephen Larsen, David Valcarcel, Paresh Vyas, Valentina Giai, Esther Natalie Oliva, Jake Shortt, Dietger Niederwieser, Moshe Mittelman, Luana Fianchi, Ignazia La Torre, Jianhua Zhong, Eric Laille, Daniel Lopes de Menezes, Barry Skikne, C L Beach, Aristoteles Giagounidis
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Amanda Tey, Briony Shaw, Luke Cardamone, Sam Shepherd, Eldho Paul, Ben Rogers, Jake Shortt
Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome. European journal of haematology 107 (2) (2021)
Lisa C Wellinger, Simon J Hogg, Dane M Newman, Thomas Friess, Daniela Geiss, Jessica Michie, Kelly M Ramsbottom, Marina Bacac, Tanja Fauti, Daniel Marbach, Laura Jarassier, Phillip Thienger, Axel Paehler, Leonie A Cluse, Conor J Kearney, Stephin J Vervoort, Joesph A Trapani, Jane Oliaro, Jake Shortt, Astrid Ruefli-Brasse, Daniel Rohle, Ricky W Johnstone
BET Inhibition Enhances TNF-Mediated Antitumor Immunity. Cancer immunology research (2021)
Jonathan Wing Kit Wong, Meaghan Wall, Gregory Philip Corboy, Nadine Taubenheim, Gareth Peter Gregory, Stephen Samuel Opat, Jake Shortt
Failure of tofacitinib to achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations. Cold Spring Harbor molecular case studies 6 (4) (2020)
Maciej Tatarczuch, Erin Paul, Michael Gilbertson, Gareth Peter Gregory, Constantine S Tam, Hang Quach, Ali Bazargan, Robin Filshie, Matthew Ku, Amanda Tey, Jake Shortt, Stephen Samuel Opat
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy. Leukemia & lymphoma 62 (1) (2020)
Sumita Ratnasingam, Patricia A Walker, Huy Tran, Zane S Kaplan, James D McFadyen, Huyen Tran, Tse-Chieh Teh, Shaun Fleming, John V Catalano, Sanjeev D Chunilal, Anna Johnston, Stephen S Opat, Jake Shortt
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases. Blood advances 1 (1) (2016)